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Objectives: To describe the presentation, preoperative assessment and postoperative management of patients presenting 
with an infrarenal abdominal ortic aneurysm following a previous cardiac transplant. 
Methods: The case histories of three patients have been examined and a literature review performed. 
Conclusions: The majority of patients developing aortic aneurysms had undergone cardiac transplantation f r ischaemic 
cardiomyopathy and thus require detailed assessment of cardiac function preoperatively to exclude accelerated coronary 
artery disease in the graft. Full invasive cardiac monitoring during surgery is mandatory to maintain haemodynamic 
stability in patients with a dennervated heart and to avoid postoperative renal failure. The higher incidence of pulmonary 
and wound complications are discussed, together with protocols for maintaining adequate immunosuppression. Fi ally, 
data supporting a higher prevalence and more rapid expansion of aortic aneurysms in immunosuppressed patients is 
considered and evidence-based r commendations made regarding aneurysm screeening in these patients. 
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Introduction 
Cardiac transplantation is an accepted therapeutic op- 
tion for selected patients with end-stage cardiac failure, 
with ischaemic ardiomyopathy (CM) accounting for 
39-65% of recipients. 1'2 Life expectancy of transplant 
patients has improved considerably since the in- 
troduction of cyclosporine, with reported survival 
rates of up to 94%, 79% and 72% at 1, 5 and 10 years, 
respectively. 1'3 Thus, it is increasingly ikely that these 
patients will develop extra-cardiac manifestations of 
their atherosclerosis. 
This paper reports the elective repair of three in- 
frarenal aortic aneurysms (AAA) in cardiac trans- 
plant patients and discusses their preoperative, 
perioperative and postoperative management. A lit- 
erature review suggests that the natural history of 
AAA in these patients may differ from that in non- 
transplant patients, and thus the role of screening is 
considered. 
* Address correspondence to: M. J. Gough. 
Patients and Methods 
Case 1 
A 47-year-old male who underwent transplantation 
(ischaemic ardiomyopathy) in April 1990 had mild 
aortic dilatation (3.2 cm) prior to surgery. A computed 
tomography (CT) scan in August 1994 demonstrated 
a 5.7 cm diameter AAA. His medical history included 
post-transplantation hypertension, hyperlipidaemia, 
mild chronic renal insufficiency (serum creatinine 
180umol/1; normal range; 50-140) and reflux oeso- 
phagitis. Current medication comprised cyclosporine, 
azathioprine, prednisolone, nifedipine, captopril, fru- 
semide, aspirin and cimetidine. 
The AAA was impalpable due to obesity (wt: 116 kg), 
although a 2.5 cm left femoral artery aneurysm was 
noted. The chest X-ray and pulmonary function tests 
were normal, an ECG showed a sinus rhythm with 
superadded recipient P-waves, and annual post-trans- 
plantation angiography confirmed normal coronary 
vessels, with no evidence of rejection on endo- 
myocardial biopsy. 
Aortography mirrored the CT findings and thus an 
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aorto-bifemoral Y-graft was performed. Perioperative 
monitoring included invasive arterial, central venous 
and pulmonary artery wedge pressure (PAWP) meas- 
urements, and an epidural catheter was employed for 
postoperative analgesia. Anaesthesia was maintained 
with low-dose isoflurane and nitrous oxide, whilst 
nitroglycerin and dopamine infusions were instituted 
for blood pressure (BP) control and optimisation of 
renal perfusion (urine output maintained at 1-2 ml/  
kg/h). Adequate preload was achieved by a CVP of 
9-11 mmHg and a PAWP of 18 mmHg. 
Antibiotic prophylaxis (cephradine i g, 8-hourly i.v.) 
was continued until all catheters had been removed. 
Cyclosporine and azathioprine were administered via 
a nasogastric tube, and i.v. hydrocortisone given in 
reducing doses to replace oral prednisolone. Serum 
cyclosporine l vels and white cell count were mon- 
itored daily. The patient made an uneventful recovery 
and was discharged on the 14th day. He remains well 
at 18-months' follow-up. 
Case 2 
A 55-year-old male had a cardiac transplant in July 
1993 (ischaemic ardiomyopathy) following coronary 
artery bypass surgery 3 years earlier. Pre-transplant 
ultrasound confirmed a normal aorta (1.9cm dia- 
meter), although angiography in August 1995 (symp- 
toms of calf claudication) demonstrated a saccular 
infrarenal AAA and left iliac and bilateral superficial 
femoral artery arteriosclerosis. The AAA (5.2 cm dia- 
meter on ultrasonography) was impalpable due to 
obesity (109kg). Medical history included insulin- 
dependent diabetes, mild chronic obstructive airways 
disease, a minor stroke in 1991, hypertension, hyper- 
lipidaemia, chronic renal insufficiency (serum 
creatinine 275 umol/1) and gout, for which he was 
receiving cyclosporine, azathioprine, diltiazem, 
bendrofluazide, insulin and a ventolin inhaler. 
Respiratory function tests confirmed mild, re- 
versible, chronic obstructive airways disease (COAD), 
whilst an ECG showed a sinus tachycardia, recipient 
P-waves and a right bundle branch block (RBBB). 
Coronary angiography and endomyocardial biopsy 
were normal. 
The AAA was repaired with an aorto-bifemoral Y- 
graft. Anaesthetic management, antibiotic prophylaxis 
and immunosuppression were as for case 1. Post- 
operative recovery was complicated by adult res- 
piratory distress yndrome and acute-on-chronic renal 
failure requiring ventilation and haemodialysis for 7 
days. Subsequent recovery was uneventful, and the 
patient was discharged on day 21 with a creatinine of 
250 umol/1. He remains well at 1 year. 
Case 3 
A 41-year-old male received a cardiac transplantation 
in September 1990 for ischaemic ardiomyopathy fol- 
lowing coronary artery bypass surgery 12 months 
earlier. Mild aortic dilatation (3.1 cm diameter) was 
noted prior to surgery, although a saccular infrarenal 
AAA was demonstrated during coronary angiography 
(normal coronary vessels, no evidence of rejection) in 
September 1991 (4.3 x 5 cm on CT scan). His medical 
history included post-transplantation hypertension, 
hyperlipidaemia and reflux oesophagitis, and med- 
ication included cyclosporine, azathioprine, frumil, 
aspirin and ranitidine. Renal biochemistry and pul- 
monary function tests were normal, whilst an ECG 
showed sinus tachycardia with RBBB. 
Although the AAA was successfully replaced with 
a tube graft (discharged on day 10), the patient was 
readmitted 6 months later with congestive cardiac 
failure. Coronary angiography indicated marked pro- 
gression of coronary atherosclerosis, and the patient 
died 2 months later despite intensive medical treat- 
ment. 
Discussion 
Patients may be referred to a vascular surgeon for a 
number of reasons following cardiac transplantation. 
These include iatrogenic complications of cardio- 
pulmonary bypass and either occlusive or aneurysmal 
peripheral vascular disease. Although surgical mor- 
bidity and mortality may not be increased in these 
patients, careful consideration of their preoperative, 
intraoperative and postoperative management is
required. 
Preoperative management 
Cardiovascular assessment. Allograft rejection and ac- 
celerated coronary artery disease (CAD) may com- 
plicate cardiac transplantation, with CAD occurring 
in 4-30% of patients within 3 years and accounting 
for one-third of late deaths. 4'5 These patients do not 
experience angina (cardiac denervation), and thus pre- 
operative coronary angiography and endomyocardial 
biopsy are essential. 
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After cardiac transplantation the ECG often shows 
a sinus tachycardia (parasympathetic denervation6), 
recipient P-waves, and a right bundle branch block7 
However, significant achyarrhythmias may reflect 
allograft rejection or accelerated CAD, 8 whilst 
bradyarrhythmias might indicate the need for pre- 
operative cardiac pacing. 7
Hypertension occurs in 50-90% of patients after 
transplantation, 9'~° often being precipitated by 
immunosuppressive drugs or neuroendocrine ab- 
normalities. ~°Whilst control may be difficult, 1~ sodium 
restriction, diltiazem and angiotensin-converting- 
enzyme inhibitors are often effective. 
Pulmonary function. Whilst severe COAD is a relative 
contraindication to cardiac transplantation, all of our 
patients had smoked and were markedly obese. Their 
immunosuppressive therapy and perhaps impaired 
exercise tolerance may contribute to the latter. Routine 
pulmonary function tests should be performed and 
bronchodilators prescribed for significant reversible 
bronchospasm. 
Renal function. The renal vasoconstrictive effect of cy- 
closporine, post-transplantation hypertension and the 
nephrotoxic effect of angiotensin-converting e zyme 
inhibitors may all contribute to the chronic renal in- 
sufficiency after cardiac transplantation. ~2 Serum cre- 
atinine was elevated in two of our three patients, with 
the third showing a temporary rise postoperatively. 
Avoidance of nephrotoxic drugs, adequate pre- 
operative hydration, peri- and postoperative haemo- 
dynamic stability, and optimising renal perfusion with 
dopamine, may help preserve renal function. 
either intravenoulsy or via the nasogastric tube, with 
daily monitoring of serum cyclosporine l vels and the 
white blood cell count. For patients taking pred- 
nisolone, appropriate high doses of i.v. hydrocortisone 
are given, but are reduced over 3-5 days to the main- 
tenance dose. 
Infection risk. Immunosuppression i creases sus- 
ceptibility to infection and strict asepsis should be 
observed during insertion of indwelling catheters. 
These should be removed as soon as possible post- 
operatively and prophylactic antibiotics administered 
until this time. 
Significant weight gain following transplantation is 
common, ~5 and both obesity and long-term cortico- 
steroids increase the risks of pulmonary and wound 
complications. 16 Despite meticulous wound care, two 
of our three patients developed significant wound 
problems. 
Complications. Perioperative myocardial infarction, an 
important complication of routine aortic aneurysm 
surgery, is unusual following cardiac transplantation 
if annual coronary angiography has demonstrated nor- 
mal coronary arteries. Pulmonary complications are 
common in these patients, who have usually smoked 
and may have underlying respiratory disease. Fur- 
thermore, obesity may limit postoperative mobility, 
thus necessitating vigorous postoperative physio- 
therapy. Epidural analgesia may also reduce the risk 
of pulmonary complications, 17 although the catheter 
should be removed within 72 h because of the risk of 
sepsis. 
Anaesthetic management 
Anaesthetic management requires special con- 
sideration, 13and in particular obesity may pose con- 
siderable anaesthetic risks. 14 Furthermore, changes in 
cardiac output by the denervated heart depend upon 
the Frank-Starling law, and maintenance of an ad- 
equate preload and avoidance of hypovolaemia are 
critical. This requires invasive monitoring of both CVP 
and PAWP. Finally, anaesthetic agents which cause 
minimal myocardial depression should be used. 
Postoperative management. 
Immunosuppressive th rapy. This should be maintained 
with cyclosporine and azathioprine administered 
Natural History of Aortic Aneurysms in Cardiac 
Transplant Patients 
The majority of AAAs after transplantation ccur in 
patients who presented with ischaemic cardio- 
myopathy (Table 1) - an extracardiac manifestation f 
their atherosclerosis. Furthermore, these aneurysms 
appear to expand more rapidly (0.74-1.75cm/ 
year) 1'18 than other AAAs (0.2-0.5 cm/year), 19'2° and 
this is apparently confirmed by our report (1.35 cm/ 
year). Thus, combined ata from all series indicate a 
mean aneurysm growth rate of 1.10 (_+ 0.61)cm/year 
(Table 2). This phenomenon might be explained by 
factors which promote or accelerate atherosclerosis in 
transplant patients, including hyperlipidaemia 
and immunosuppressive therapy. Furthermore, ex- 
perimental evidence suggests that corticosteroids may 
promote both the development and rupture of aortic 
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Table 1. Previous series describing the development of AAA in cardiac transplantation patients. 
Authors Indication for AAA AAA Shape of Sex Age at 
cardiac symptom surgery AAA AAA 
transplantation repair 
(year) 
Interval Size of 
between AAA at 
cardiac and repair 
aortic surgery (cm) 
Op. 
mortality 
Infrarenal AAA 
Reitz et al} 
Reichman et Cd. 32 
Piotrowski et al} 
MacIntyre et al. 5 
Bull et al. 33 
Benvenisty et al. 28 
Shenaq et aL 34 
Chandrasekar 
et al? s 
Defraigne t al. 18 
Ammori et al. 
(this paper) 
Ischaemic CM Pain Elective Fusiform Male 50/51 
Ischaemic CM Pain Elective ? Male 51 
Ischaemic CM Pain (NR) Etnergency ? Male 61 
Ischaemic CM Pain Elective ? Male 61 
Ischaemic CM Asympt. Elective Fusiform Male 55 
Ischaemic CM Pain (NR) Emergency ? Male 66 
Ischaemic CM Ruptured Emergency ? Male 60 
Ischaemic CM Asympt. Elective ? Male 56/57 
Ischaemic CM Pain (NR) Emergency ? Male 55 
Ischaemic CM Asympt. Elective ? Male 57 
Ischaemic CM Rupture Emergency ? ? ? 
Ischaemic CM Asympt. Elective ? ? ? 
(six patients) 
Ischaemic CM Pain (NR) Emergency ? Male 52 
Ischaemic CM Asympt. Elective ? Male 52 
Ischaemic CM Asympt. Elective ? Male 63 
Ischaemic CM Asympt. Elective ? Male 59 
Ischaemic CM Rupture Emergency ? Male 61 
Valvular CM Asympt. Elective ? Male 63 
Idiopathic CM Asympt. Elective ? Male 63 
Ischaemic CM Asympt. Elective ? Male 64 
Ischaemic CM Asympt. Elective Fusiform Male 51 
Ischaemic CM Asympt. Elective Saccular Male 57 
Ischaemic CM Asympt. Elective Saccular Male 42 
Suprarenal AAA 
Benvenisty et al} 8 Ischaemic CM Rupture Emergency ? Male 44 
Oz et al. a6 ? ? Elective ? Male 45 
5 year +8 month 8 No 
4 year+2 month 12 No 
2 year 11 No 
2 year 5.2 No 
2 year÷4 month 5.5 No 
2 year 5.9 No 
2 month 4 Died 
18 month 4.8 No 
3 year 4.1 No 
2 year+6 month 6.5 No 
2 month ? Died 
? ? No 
4 month ? No 
5 year ? No 
3 month ? ? 
6 month ? ? 
6 year 5.0 No 
4 year 5.3 No 
1 year 6.5 No 
2 year 5.3 No 
4 year+4 month 5.7 No 
2 year÷l  month 5.2 No 
1 year 5.0 No 
13 month ? No 
? 8.5 No 
AAA, abdominal aortic aneurysm; CM, cardiomyopathy; NR, non-ruptured. 
Table 2. Expansion rate of reported AAA in cardiac transplant patients. 
Authors Infrarenal aortic diameter (cm) 
Pre-cardiac Post-cardiac 
transplant transplant 
At AAA 
repair 
Growth rate 
(cm/year) 
Piotrowski et al} 
Chandrasekar et al? 5 
Defraigne t al} 8 
Ammori et al. (this paper) 
3.4 - -  5.5 0.84 
4.5 - -  5.9 0.80 
3.5 - -  4.0 0.50 
3.5 - -  4.8 0.67 
1.5 - -  4.1 0.87 
- -  3.2cm at3year 5 0.60 
- -  3.0cm at2year 5.4 1.20 
4.0 - -  6.5 2.50 
3.0 - -  5.3 1.15 
3.2 - -  5.7 0.57 
1.9 - -  5.2 1.58 
3.1 - -  5.0 1.9 
aneurysms,  21 wh i l s t  aneurysmal  d i sease  appears  more  
common,  and  deve lops  10 years  earl ier,  in pat ients  
rece iv ing  s tero ids  for auto immune diseases.  22 Final ly,  
inc reased  aort ic  haemodynamic  stress fo l low ing  a r ise 
in card iac  e ject ion f ract ion  1'18 and  sys temic  hyper -  
tens ion  may acce lerate  aneurysm en largement  23~5 and  
promote  rupture .  26'27 
It might  be  cons idered  unusua l  that  two  of our  
pat ients  had  saccu lar  aneurysms,  a l though Benven is ty  
et al. 28 have  also repor ted  the deve lopment  of a saccu lar  
aneurysm of the descend ing  aor ta  after  t rans-  
p lantat ion .  Unfor tunate ly ,  aneurysm morpho logy  is 
not  descr ibed  in any  o ther  repor ts  (Table 1). However ,  
g iven  the poss ib i l i ty  that  saccu lar  aneurysms may be 
more  common in these  pat ients ,  it is wor th  cons ider -  
ing  the i r  natura l  h istory.  Thus ,  wh i l s t  Our ie l  et a l}  9 
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reported that saccular aneurysms rupture less often 
than fusiform aneurysms, Faggioli et al. 3~ have sug- 
gested that saccular outpouchings in the aneurysm 
wall increase the risk of early rupture. Thus, early 
repair of saccular aneurysms may be justified. 
In view of the foregoing discussion it is logical to 
consider the role of aneurysm screening in transplant 
patients, particularly as the overall incidence of an- 
eurysm development is 4.3%, increasing to 10.5% in 
patients undergoing transplantation for ischaemic 
cardiomyopathy. This compares to a prevalence of2% 
in males aged 65-74 years, in the general population. 3~ 
It  is also apparent that AAA in transplant patients 
may be impalpable due to obesity, and thus routine 
ultrasonography is required for screening. However, 
because there are no reports of aneurysm development 
in female patients (Table 1), it might be reasonable to 
restrict screening to males. 
Finally, the role of endovascular neurysm repair 
might be considered inthis group of patients. Certainly 
a reduced aortic occlusion time might be beneficial 
from the cardiac point of view. Similarly, avoidance 
of an abdominal wound and early mobilisation should 
reduce pulmonary complications, while the absence 
of a postoperative il us allows easy administration of
immunosuppressive th rapy. However, current ech- 
niques for stent-grafting require groin incisions which 
are more susceptible to infection than abdominal 
wounds, and this could increase the risk of graft 
infection, particularly when performed in the angio- 
graphy suite where sterility may be inferior to that of 
an operating theatre. 
In summary, aortic aneurysms in cardiac transplant 
patients hould be considered for early repair, as they 
appear to have a rapid expansion rate and concomitant 
corticosteroid therapy may increase the risk of rupture. 
Such a policy should be relatively safe, because these 
patients usually have relatively normal cardiac func- 
tions and this almost certainly explains the absence of 
mortality for elective aneurysm repair in the published 
series. 
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